使用CRISPR-Cas9技术在癌症治疗中准长非编码RNA:精确瘤学的新范式
Rahul Kumar Mahato1, Srinjan Bhattacharya1, Naina Khullar2
1Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India.
Journal of biotechnology
|December 8, 2023
概括
克里斯普尔-Cas9技术为癌症治疗提供了一种针对长非编码RNA (lncRNAs) 的新方法. 这一策略对开发个性化癌症治疗和克服抗药性有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 癌症仍然是全球主要的死亡原因,需要新的诊断和治疗策略.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发育和进展中的作用.
- 识别新的分子标和生物标志物对于推进癌症患者护理至关重要.
研究的目的:
- 探索CRISPR-Cas9基因编辑技术的应用,以准癌症中的lncRNAs.
- 审查 lncRNA 向作为癌症管理治疗策略的潜力.
- 讨论针对个性化癌症治疗的CRISPR-Cas9和lncRNA研究的整合.
主要方法:
- 关于CRISPR-Cas9技术及其在lncRNA研究中的应用的当前文献的综述.
- 讨论CRISPR-Cas9介导的针对 lncRNAs的策略,包括干扰,激活和淘汰.
- 探索将CRISPR-Cas9与高通量功能基因组学相结合,以识别关键的lncRNAs.
主要成果:
- 克里斯普尔-Cas9提供了一个多功能平台,可以精确地准 lncRNAs.
- 克里斯普尔-Cas9可以识别特定癌症亚型生存所必需的lncRNAs.
- 结合CRISPR-Cas9介导的lncRNA向与其他疗法的协同方法可以克服药物耐药性.
结论:
- 通过CRISPR-Cas9介导的lncRNA向是创新的癌症治疗方法的一个有希望的途径.
- 这种方法促进了定制治疗和个性化癌症治疗的开发.
- 整合lncRNA研究和CRISPR-Cas9技术为改善癌症治疗结果提供了显著的潜力.
相关概念视频
01:59CRISPR
51.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:53CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K